Drugplain

Medroxyprogesterone Acetate Injectable Suspension 150 mg/mL

medroxyprogesterone acetate · INJECTION, SUSPENSION · Hikma Pharmaceuticals USA Inc.

No Recall History
Plain English

Medroxyprogesterone Acetate Injectable Suspension is a injection, suspension containing medroxyprogesterone acetate at 150 mg/mL, taken intramuscular. Manufactured by Hikma Pharmaceuticals USA Inc..

Key Facts

Brand Name
Medroxyprogesterone Acetate Injectable Suspension
Generic Name
medroxyprogesterone acetate
NDC Code (Product)
24201-150
Manufacturer
Hikma Pharmaceuticals USA Inc.
Strength
150 mg/mL
Dosage Form
INJECTION, SUSPENSION
Route
INTRAMUSCULAR
Marketing Status
Application #
ANDA214309
Marketing Start
05/01/2023

Recall History

No Recall History

Frequently Asked Questions

What is Medroxyprogesterone Acetate Injectable Suspension used for?

Medroxyprogesterone Acetate Injectable Suspension contains medroxyprogesterone acetate. It is a injection, suspension taken intramuscular. Consult your doctor for specific uses.

Is Medroxyprogesterone Acetate Injectable Suspension a controlled substance?

Medroxyprogesterone Acetate Injectable Suspension is not classified as a controlled substance by the DEA.

What is the generic name for Medroxyprogesterone Acetate Injectable Suspension?

The generic name for Medroxyprogesterone Acetate Injectable Suspension is medroxyprogesterone acetate. There are 12 other brand versions of medroxyprogesterone acetate.

What is the NDC code for Medroxyprogesterone Acetate Injectable Suspension 150 mg/mL?

The NDC (National Drug Code) for Medroxyprogesterone Acetate Injectable Suspension 150 mg/mL is 24201-150, listed by Hikma Pharmaceuticals USA Inc..

Product NDC

24201-150

Package NDC

24201-150-01

Other Medroxyprogesterone Brands

See all →

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)